Anna Dodero, Roberto Crocchiolo, Francesca Patriarca, Rosalba Miceli, Luca Castagna, Fabio Ciceri, Stefania Bramanti, Niccolo Frungillo, Raffaella Milani, Flavio Crippa, Federico Fallanca, Emanuela Englaro and Paolo Corradini Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantation Cancer 116
Article first published online: 21 JUL 2010 | DOI: 10.1002/cncr.25357
Disease assessment on an [18-F]fluorodeoxyglucose positron emission tomography (PET) scan before allogeneic stem cell transplantation was capable of predicting long-term survival in patients with recurrent and chemosensitive Hodgkin lymphoma or aggressive non-Hodgkin lymphoma, because the patients who had negative PET scans were at lower risk of recurrence and had better progression-free and overall survival than the patients who had positive PET scans. The predictive value of PET was independent of graft-versus-host disease and the graft-versus-lymphoma effect.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field